article thumbnail

Allucent to expedite Covid-19 booster vaccines development

Pharmaceutical Business Review

We are excited to leverage our expertise and resources to help develop next-generation booster vaccines that will enhance global immunity and save lives. This award results from our focused investment in countering infectious diseases and further builds upon our growing federally funded clinical trials portfolio.”

article thumbnail

Lipid Nanoparticles Immunogenicity & Toxicity | December 6-8, 2022

pharmaphorum

Following the success of LNP-mRNA vaccines, we have seen an influx of novel types of lipids based nanocarriers over the last 12 months, progress has been made to minimize immuno-toxicity challenges – from maximizing therapeutic window to fine-tuning the immune response. .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Developing new treatment regimens for HIV

European Pharmaceutical Review

For example, broadly neutralising antibodies (bNAbs), capsid inhibitors and maturation inhibitors all might play a role in fighting HIV from the initial binding and fusion of HIV into immune cells, to where it integrates into the cell, out to its assembly and maturation.

article thumbnail

Top 9 Takeaways From 2232 People With Hashimoto’s

The Thyroid Pharmacist

Vitamin D supports the immune system by enhancing the pathogen-fighting effects of white blood cells, which are important parts of immune defense. Supplementing with vitamin D can especially help to improve mood and cognitive function during the winter months, as well as improve immune function. I recommend doses of 1.5

Immunity 110
article thumbnail

The future of medical cannabis development in Europe

European Pharmaceutical Review

Cannabis complications There are notable complexities to researching medical cannabis using a linear approach to clinical translation. 5 These compounds have been shown in pre-clinical studies to have an array of potential effects on the immune, nervous, cardiovascular, respiratory and endocrine systems. 2023 Mar 4;16(3):257-66.

article thumbnail

The ‘failure’ of clinical trials in the search for COVID-19 treatments

pharmaphorum

He was until recently an Emeritus Professor of Clinical Pharmacology at the University of Claude Bernard Lyon 1, and has been a scientific director at the French Institute for Health and Medical Research (Inserm), advisor to the General Surgeon and is still a member of a number of scientific societies in Europe and the United States.

Vaccines 105
article thumbnail

Twenty Women Leaders In Healthcare Industry

PharmaShots

and medical doctor in clinical pharmacology Other Affiliations: She is a member of the Board of Directors of L’Oréal S.A and Banco Bilbao Vizcaya Argentaria S.A With more than $50 billion in annual global revenue, Janssen has grown to be the second-largest innovative pharmaceutical company under her direction.